TY - JOUR T1 - Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review JO - Revista Portuguesa de Cardiologia T2 - AU - Caldeira,Daniel AU - Pereira,Hélder SN - 08702551 M3 - 10.1016/j.repc.2018.05.020 DO - 10.1016/j.repc.2018.05.020 UR - https://revportcardiol.org/pt-adjuvant-antithrombotic-therapy-in-st-elevation-articulo-S0870255117309964 AB - This article reviews the major pharmacologic features of, and clinical evidence on, adjuvant medical therapy in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention. These drugs include oral antiplatelets (aspirin and P2Y12 inhibitors such as clopidogrel, prasugrel and ticagrelor), intravenous antiplatelet agents (the P2Y12 inhibitor cangrelor, GP IIb/IIIa inhibitors such as abciximab, eptifibatide and tirofiban), and intravenous anticoagulant agents (unfractionated heparin, low molecular weight heparin and bivalirudin). ER -